/
Markets
Crypto
News
Forecasts
Forex Brokers
Calendars
Macro Data
About us
Commodity Prices
Currency Rates
Cryptocurrency Prices
Global Market Indices
Stock Prices
ETF Prices
Cryptocurrency Prices
Crypto Exchanges
Crypto Wallets
Cryptocurrency News
Cryptocurrency Forecasts
Commodity News
Forex News
Crypto News
Stock Market News
Economic News
Opinions
Broker News
Commodities
Forex
Crypto
Indices
Natural Gas Forecasts
Gold Forecasts
WTI Crude Oil Forecasts
S&P 500 Forecasts
Forex Brokers Reviews
Best Brokers Guides
Compare Forex Brokers
Best Forex Brokers
Best Forex Platforms
Best MT4 Brokers
Best for Trading Gold
Best Brokers in Australia
Best Brokers for Beginners
Best Brokers in UK
Brokers Promotions
Stock Brokers
Economic Calendar
Earnings Calendar
Splits Calendar
Dividends Calendar
Holiday Calendar
IPO Calendar
Stock Screener
Currency Converter
Global Macro indicators
Sovereign Credit Ratings
Global Major Indicators
Interest Rates
United States Indicators
China Indicators
Australia Indicators
Euro Area Indicators
About us
Contact Us
Terms Of Use
Become A Contributer
EUR/USD
-0.16%
Natural Gas
+5.35%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
+0.12%
VIX
N/A
Economic Calendar
EUR/USD
-0.16%
Natural Gas
+5.35%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
+0.12%
VIX
N/A
Economic Calendar
BTC
N/A
ETH
N/A
XRP
N/A
ADA
N/A
SOL
N/A
Review
Review
Review
The Week Ahead: Central Bankers, Services PMIs, and UK Inflation in Focus
about 17 hours ago
Five Things to Know in Crypto This Week: BTC-Spot ETF Inflows and SEC vs. Ripple
1 day ago
Crypto News Today: U.S. Senate Votes against SEC | CME Group to List BTC | JPMorgan on BTC Mining
2 days ago
Gold May Test The $2500 Level In May
2 days ago
Italy: Tax Breaks, Investment Delays, Rising Debt-to-GDP Increase the Need for Fiscal Consolidation
2 days ago
Annual Inflation Stable at 2.4% in the Euro Area; Core Steady at 2.7%
2 days ago
Silver Prices Forecast: Fed Minutes Expected to Influence This Week
about 13 hours ago
Natural Gas News: Will Sellers Emerge at $2.686 to $2.867 Resistance?
about 14 hours ago
Gold Prices Forecast: Will China Stimulus and Rate Cut Hopes Persist?
about 16 hours ago
XRP News Today: Ripple Expansion Plans, Court Rulings, and Appeals
about 16 hours ago
Bitcoin (BTC) News Today: BTC Stability as ETF Inflows Counter Fed Rate Cut Jitters
about 16 hours ago
USD/JPY Weekly Forecast: Services PMIs, Inflation, and Central Bankers in Focus
about 17 hours ago
Quick Links
:
Forecasts
Economic Calendar
Commodities
Trade Now
ad
ad
Advertisement
Advertisement
home
stocks
YMAB
news
Y-Mabs Therapeutics Inc
Follow
YMAB
(
Nasdaq - US
)
N/A
11.56
-0.29 (-2.45%)
in
:
usd
•
As of: May 17, 2024 15:59
UTC -4
Open
11.82
High
11.98
Low
11.50
Overview
News & Analysis
Profile
Financials
Advanced Chart
History
Earnings
Latest News
Seeking Alpha
May 8, 2024
Y-mAbs Therapeutics, Inc. (YMAB) Q1 2024 Earnings Call Transcript
YMAB
-2.45%
Zacks Investment Research
May 7, 2024
Y-mAbs Therapeutics, Inc. (YMAB) Reports Q1 Loss, Misses Revenue Estimates
YMAB
-2.45%
Zacks Investment Research
Apr 19, 2024
New Strong Buy Stocks for April 19th
YMAB
-2.45%
DELL
+2.21%
Zacks Investment Research
Apr 17, 2024
New Strong Buy Stocks for April 17th
YMAB
-2.45%
CORT
+2.11%
Zacks Investment Research
Mar 28, 2024
Wall Street Analysts Think YmAbs Therapeutics (YMAB) Could Surge 31.33%: Read This Before Placing a Bet
YMAB
-2.45%
Zacks Investment Research
Mar 20, 2024
YmAbs Therapeutics (YMAB) Surges 8.2%: Is This an Indication of Further Gains?
YMAB
-2.45%
Zacks Investment Research
Mar 12, 2024
Wall Street Analysts See a 31.41% Upside in Y-mAbs Therapeutics, Inc. (YMAB): Can the Stock Really Move This High?
YMAB
-2.45%
Zacks Investment Research
Mar 5, 2024
Are You Looking for a Top Momentum Pick? Why Y-mAbs Therapeutics, Inc. (YMAB) is a Great Choice
YMAB
-2.45%
Seeking Alpha
Mar 1, 2024
Y-mAbs Therapeutics, Inc. (YMAB) Q4 2023 Earnings Call Transcript
YMAB
-2.45%
Zacks Investment Research
Feb 29, 2024
Y-mAbs Therapeutics, Inc. (YMAB) Reports Q4 Loss, Tops Revenue Estimates
YMAB
-2.45%
Zacks Investment Research
Feb 22, 2024
Earnings Preview: Y-mAbs Therapeutics, Inc. (YMAB) Q4 Earnings Expected to Decline
YMAB
-2.45%
Zacks Investment Research
Feb 13, 2024
Y-mAbs Therapeutics, Inc. (YMAB) Moves 9.5% Higher: Will This Strength Last?
YMAB
-2.45%
Seeking Alpha
Nov 14, 2023
Y-mAbs Therapeutics, Inc. (YMAB) Q3 2023 Earnings Call Transcript
YMAB
-2.45%
Zacks Investment Research
Nov 13, 2023
Y-mAbs Therapeutics, Inc. (YMAB) Reports Q3 Loss, Lags Revenue Estimates
YMAB
-2.45%
Zacks Investment Research
Nov 8, 2023
All You Need to Know About Y-mAbs Therapeutics, Inc. (YMAB) Rating Upgrade to Strong Buy
YMAB
-2.45%
Seeking Alpha
Oct 11, 2023
Y-mAbs: They Have Earnings, But Still Seek The Big Hit
YMAB
-2.45%
Zacks Investment Research
Aug 23, 2023
Wall Street Analysts Think Y-mAbs Therapeutics, Inc. (YMAB) Could Surge 88.55%: Read This Before Placing a Bet
YMAB
-2.45%
Seeking Alpha
Aug 11, 2023
Y-mAbs Therapeutics, Inc. (YMAB) Q2 2023 Earnings Call Transcript
YMAB
-2.45%
Zacks Investment Research
Aug 10, 2023
Y-mAbs Therapeutics, Inc. (YMAB) Reports Q2 Loss, Tops Revenue Estimates
YMAB
-2.45%
Seeking Alpha
May 14, 2023
Y-mAbs Therapeutics, Inc. (YMAB) Q1 2023 Earnings Call Transcript
YMAB
-2.45%
Stocks
Popular
Currencies
Commodities
Indices
Stocks
ETFs
Crypto
Watchlist
Loading
Loading
Sponsored
Sponsored
This Section / Page contains links to the 3rd party websites of our top partners from whom we may receive compensation.
Trade With A Regulated Broker